Related Experiment Videos
Diagnostic challenges of prostatic carcinoma
1Service of Urology, La Fe Hospital, Valencia, Spain.
British Journal of Urology
|November 1, 1992
Summary
Early detection of prostate cancer remains difficult. Current methods like digital rectal examination, transrectal ultrasound, and PSA assays have limitations, necessitating further clinical trials for definitive diagnostic roles.
Area of Science:
- Urology
- Oncology
Background:
- Early detection and staging of prostate cancer present significant challenges for urologists.
- Screening asymptomatic men is not cost-effective due to low detection rates of localized tumors.
Purpose of the Study:
- To evaluate the effectiveness of current diagnostic methods for prostate cancer.
- To highlight the limitations in achieving early and accurate diagnosis and staging.
Main Methods:
- Review of commonly used diagnostic techniques: digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate-specific antigen (PSA) assay.
- Analysis of sensitivity and specificity rates for DRE and TRUS.
Main Results:
- DRE has low sensitivity and specificity despite being inexpensive.
- TRUS offers higher specificity and sensitivity but still has significant false-positive and false-negative rates (86% and 84% respectively in one study).
- PSA assay results require confirmation by other methods for early-stage prostate cancer.
Conclusions:
- No single method currently ensures safe and accurate early diagnosis and staging of prostate carcinoma.
- Clinical trials are essential to determine the definitive roles of each diagnostic method.